The A.I. Daily
Researchers extend LeCun's JEPA into universal world model
PhAI Labs expanded Yann LeCun's JEPA architecture across seven fields including robotics and biomedicine, yielding a liver cancer treatment candidate that showed promise in lab tests, though it is unclear whether it could become a therapy.